H-DL-Phe-OBzl · p-tosylate

H-DL-Phe-OBzl · p-tosylate is a racemic protected phenylalanine derivative in which the amino group is acylated as an N-hydrogen (H) form while the carboxyl functionality is masked as a benzyl ester (OBzl), and the compound is present as a p-toluenesulfonate salt to improve handling and crystallinity. The stereochemical content is DL, providing an equimolar mixture of L- and D-phenylalanine configurations at the α-carbon, which can be leveraged for method development where stereochemical bias is not required. The benzyl ester is compatible with standard peptide-coupling workflows after selective deprotection, while the aromatic phenyl side chain supports downstream derivatization and aromatic interaction studies. The p-toluenesulfonate counterion can influence salt formation and reactivity in coupling and protection/deprotection sequences, making the material suitable as a chiral-amino-acid precursor feedstock for protected amino acid synthesis and related intermediate preparation.

1. Peptide Synthesis

H-DL-Phe-OBzl · p-tosylate is used in peptide building block preparation and coupling development because it contains a protected carboxyl group as the benzyl ester and a protected amino functionality suitable for conversion into an activated coupling partner. The phenylalanine side chain provides an aromatic handle that can be incorporated into peptide sequences to create hydrophobic and π-interaction motifs. Benzyl ester masking enables controlled C-terminal strategies, including deprotection to reveal a carboxylic acid for subsequent amide bond formation or for generating defined C-terminal variants. Racemic stereochemistry can be applied in library synthesis, method screening, and peptide analog construction where stereochemical composition is intentionally varied or where downstream resolution is performed.

2. Protected Amino Acid Chemistry

H-DL-Phe-OBzl · p-tosylate functions as a protected amino acid intermediate for N- and C-group manipulation in synthetic organic chemistry, with the benzyl ester providing a stable yet removable carboxyl protecting group. The p-tosylate salt form can support reproducible handling during derivatization steps that require consistent ion pairing and solubility behavior. The α-amino center and esterified carboxyl group enable transformation into alternative protected forms, including conversion to carboxylic acid derivatives for peptide coupling chemistry or to other ester/acid variants for downstream intermediate generation. The aromatic side chain remains chemically intact under typical protection and deprotection conditions, supporting selective functional group strategies around the backbone.

3. Chiral Resolution Studies

H-DL-Phe-OBzl · p-tosylate is suitable for chiral synthesis workflows where DL phenylalanine derivatives are used as starting material for stereochemical separation or for evaluating stereoselective transformations. The presence of a defined benzyl ester and a stable salt form helps maintain structural integrity during resolution operations and subsequent conversion into enantiopure intermediates. The α-chiral center can be targeted indirectly through resolution of the racemate, enabling access to L- or D-phenylalanine-based peptide building blocks after separation. Downstream use includes preparing enantiopure protected phenylalanine derivatives for stereochemically defined peptide scaffolds, stereochemical SAR studies, and stereocontrolled synthetic methodology development.

4. Peptidomimetics And SAR

H-DL-Phe-OBzl · p-tosylate supports peptidomimetic construction and structure-activity relationship studies by supplying a phenylalanine-derived aromatic motif that can be embedded into constrained analogs or backbone-modified frameworks. The benzyl ester masking enables controlled elaboration of C-terminal functionality, including conversion into acid or alternative electrophilic forms used for scaffold assembly. Racemic incorporation can be used to probe stereochemical effects on binding mode hypotheses, while the aromatic side chain can be further functionalized to tune hydrophobicity and aromatic interaction patterns. The compound's protected amino acid architecture aligns with common synthetic routes used to generate non-natural peptide analogs and intermediate fragments for medicinal chemistry campaigns.

5. Pharmaceutical Intermediate Preparation

H-DL-Phe-OBzl · p-tosylate can be employed as a process chemistry intermediate for manufacturing routes that require protected phenylalanine derivatives as feedstock for peptide-like intermediates. The benzyl ester provides a robust protecting group for carboxyl functionality during multi-step synthesis, while the p-tosylate salt form can assist in controlling handling characteristics in bulk chemical operations. The aromatic amino acid backbone enables downstream conversion into activated coupling species, C-terminal acids, or further protected derivatives used in fine chemical synthesis. The material's compatibility with standard protection/deprotection logic supports its use in producing controlled-structure intermediates for peptide-based reagent manufacturing and industrial-scale amino acid derivative production.

6. Analytical Standards Development

H-DL-Phe-OBzl · p-tosylate is applicable to analytical method development and reference standard preparation for amino acid derivative characterization, including monitoring of protected amino acid intermediates and their conversion states. The benzyl ester and p-tosylate salt provide distinct chemical signatures that can be detected by chromatographic and spectrometric methods, supporting identity testing and impurity profiling in peptide synthesis workflows. The racemic DL composition can be used to generate calibration standards for enantiomeric mixture quantification or to validate stereochemical separation methods when paired with enantiopure comparators. The stable protected structure also facilitates preparation of defined analytical samples for studying deprotection behavior and backbone integrity during synthetic sequences.

1. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

2. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

3. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

4. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry